ClinVar Miner

Submissions for variant NM_006612.6(KIF1C):c.646C>T (p.Arg216Cys)

gnomAD frequency: 0.00001  dbSNP: rs1064796693
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000485547 SCV000573664 likely pathogenic not provided 2018-08-15 criteria provided, single submitter clinical testing The R216C variant in the KIF1C gene has been reported previously as a homozygous variant in an individual with spastic ataxia (Alfares et al., 2017). The R216C variant is not observed in large population cohorts (Lek et al., 2016). The R216C variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. In-silico analyses, including protein predictors and evolutionary conservation, support a deleterious effect. The R216C variant is in the motor domain of the KIF1C protein, where all reported missense variants are located to date (Caballero et al., 2014). We interpret R216C as a likely pathogenic variant.
Biochemical Molecular Genetic Laboratory, King Abdulaziz Medical City RCV000985162 SCV001133163 likely pathogenic Spastic ataxia 2 2019-09-26 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.